Last edition
News about "metastatic melanoma and leukaemia "
Xenetic Biosciences has extended its research collaboration with the laboratory of Dr Alexey Stepanov, Institute Investigator at Scripps Research to advance the company’s R&D programme, evaluating the combined use of systemic DNase I and CAR T-cell therapies for difficult-to-treat cancers.
Metastatic Melanoma And Leukaemia | 20/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members